CN113336308B - A method for degrading and recycling antibiotic wastewater - Google Patents
A method for degrading and recycling antibiotic wastewater Download PDFInfo
- Publication number
- CN113336308B CN113336308B CN202110468942.2A CN202110468942A CN113336308B CN 113336308 B CN113336308 B CN 113336308B CN 202110468942 A CN202110468942 A CN 202110468942A CN 113336308 B CN113336308 B CN 113336308B
- Authority
- CN
- China
- Prior art keywords
- antibiotic
- degrading
- waste water
- recycling
- wastewater
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003115 biocidal effect Effects 0.000 title claims abstract description 55
- 239000002351 wastewater Substances 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 20
- 238000004064 recycling Methods 0.000 title claims abstract description 14
- 230000000593 degrading effect Effects 0.000 title claims abstract description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims abstract description 46
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 claims abstract description 36
- 238000006243 chemical reaction Methods 0.000 claims abstract description 34
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims abstract description 33
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims abstract description 23
- 235000019253 formic acid Nutrition 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 17
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 17
- 229910021642 ultra pure water Inorganic materials 0.000 claims abstract description 11
- 239000012498 ultrapure water Substances 0.000 claims abstract description 11
- 238000003756 stirring Methods 0.000 claims abstract description 10
- 229910052759 nickel Inorganic materials 0.000 claims abstract description 8
- 239000007787 solid Substances 0.000 claims abstract description 7
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 28
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 24
- 239000001257 hydrogen Substances 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 claims description 13
- 229960001180 norfloxacin Drugs 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- KBJMLQFLOWQJNF-UHFFFAOYSA-N nickel(ii) nitrate Chemical group [Ni+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O KBJMLQFLOWQJNF-UHFFFAOYSA-N 0.000 claims description 11
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 claims description 8
- 229960000740 enrofloxacin Drugs 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 239000004098 Tetracycline Substances 0.000 claims description 7
- 229960002180 tetracycline Drugs 0.000 claims description 7
- 229930101283 tetracycline Natural products 0.000 claims description 7
- 235000019364 tetracycline Nutrition 0.000 claims description 7
- 150000003522 tetracyclines Chemical class 0.000 claims description 7
- 239000007789 gas Substances 0.000 claims description 6
- 150000002431 hydrogen Chemical class 0.000 claims description 6
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 claims description 5
- 239000000463 material Substances 0.000 abstract description 4
- 239000002699 waste material Substances 0.000 abstract description 2
- 239000003054 catalyst Substances 0.000 description 27
- 238000006731 degradation reaction Methods 0.000 description 24
- 230000015556 catabolic process Effects 0.000 description 15
- 229910006404 SnO 2 Inorganic materials 0.000 description 12
- 230000003197 catalytic effect Effects 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000004065 wastewater treatment Methods 0.000 description 2
- 208000005156 Dehydration Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000020335 dealkylation Effects 0.000 description 1
- 238000006900 dealkylation reaction Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 231100000584 environmental toxicity Toxicity 0.000 description 1
- 229910000856 hastalloy Inorganic materials 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002815 nickel Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/725—Treatment of water, waste water, or sewage by oxidation by catalytic oxidation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
- B01J23/76—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
- B01J23/835—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36 with germanium, tin or lead
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/72—Treatment of water, waste water, or sewage by oxidation
- C02F1/722—Oxidation by peroxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2305/00—Use of specific compounds during water treatment
- C02F2305/02—Specific form of oxidant
- C02F2305/023—Reactive oxygen species, singlet oxygen, OH radical
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Materials Engineering (AREA)
- Treatment Of Water By Oxidation Or Reduction (AREA)
- Catalysts (AREA)
Abstract
本发明公开一种抗生素废水降解并资源化的方法,称取镍源和二氧化锡,加入超纯水溶解,静置后水浴搅拌至干燥,高温还原后随炉冷却,取出固体研磨;将研磨后的粉末、抗生素废水添加至反应釜中,拧紧反应釜,搅拌下进行氧化反应,降解抗生素并得到甲酸;本发明能够高效去除废水中含有的高浓度抗生素,并且资源化产甲酸,实现了污染物资源化,变废为宝。The invention discloses a method for degrading and recycling antibiotic wastewater. Nickel source and tin dioxide are weighed, dissolved in ultrapure water, left standing, stirred in a water bath until dry, reduced at high temperature and then cooled in a furnace, and the solid is taken out for grinding; The resulting powder and antibiotic wastewater are added to the reaction kettle, the reaction kettle is tightened, and the oxidation reaction is carried out under stirring to degrade the antibiotics and obtain formic acid; the method can efficiently remove the high-concentration antibiotics contained in the wastewater, and generate formic acid by recycling, thereby realizing pollution. Material resources, turning waste into treasure.
Description
技术领域technical field
本发明涉及抗生素废水治理领域,涉及一种抗生素废水降解并资源化的方法。The invention relates to the field of antibiotic wastewater treatment, and relates to a method for degrading and recycling antibiotic wastewater.
背景技术Background technique
由于抗生素具有优异的抗菌性能,在医药、农用药、水产养殖、畜牧业等多个行业之中被大量的使用,40%-90%以母体或代谢物的形式进入环境,造成严重的环境危害。研究人员对抗生素废水处理展开了大量的探索,不过目前的大部分处理技术,仅仅进行到去除COD(化学需氧量)的层面,对于抗生素的资源化研究未见报道。Because antibiotics have excellent antibacterial properties, they are widely used in medicine, agricultural drugs, aquaculture, animal husbandry and other industries, and 40%-90% enter the environment in the form of parent or metabolite, causing serious environmental hazards. . Researchers have carried out a lot of exploration on antibiotic wastewater treatment, but most of the current treatment technologies only go to the level of COD (chemical oxygen demand) removal, and there is no report on the resource utilization of antibiotics.
因此,目前寻找一种资源化处理抗生素废水污染的方法,削减抗生素环境毒害性,降低抗性基因的传播,是当前亟需解决的问题。Therefore, it is an urgent problem to find a way to recycle the pollution of antibiotic wastewater, reduce the environmental toxicity of antibiotics, and reduce the spread of resistance genes.
水在高温高压下,理化参数发生改变,传质传热性能大大提高,反应过程迅速高效。因此亚超临界水技术处置抗生素废水具有广阔的前景,不用预先进行脱水处理,亚超临界水技术在有机物资源化方面应用广泛,抗生素的资源化降解具备可行性,不过由于抗生素的难降解性,在反应中并不是那么容易实现。Under high temperature and high pressure, the physical and chemical parameters of water are changed, the mass and heat transfer performance is greatly improved, and the reaction process is fast and efficient. Therefore, the sub-supercritical water technology has broad prospects for the treatment of antibiotic wastewater without pre-dehydration treatment. The sub-supercritical water technology is widely used in the recycling of organic matter. Not so easy to implement in react.
发明内容SUMMARY OF THE INVENTION
本发明提供一种制备方便、经济、效果显著的抗生素废水处置方法,具体包括以下步骤:The invention provides a method for treating antibiotic wastewater with convenient preparation, economy and remarkable effect, which specifically comprises the following steps:
(1)称取镍源和二氧化锡,加入超纯水溶解,静置后在水浴锅下搅拌至干燥,放在管式炉中,高温还原后随炉冷却,取出固体研磨;(1) Weigh nickel source and tin dioxide, add ultrapure water to dissolve, stir to dryness under water bath after standing, place in tube furnace, cool with furnace after high temperature reduction, take out solid and grind;
(2)将步骤(1)研磨后的粉末、抗生素废水添加至反应釜中,拧紧反应釜,搅拌下进行氧化反应,降解抗生素同时得到甲酸。(2) adding the ground powder and antibiotic waste water in step (1) to the reaction kettle, tightening the reaction kettle, and carrying out an oxidation reaction under stirring to degrade the antibiotic to obtain formic acid simultaneously.
步骤(1)镍源为硝酸镍、氯化镍或者其他镍盐,镍源和二氧化锡物质的量比为1~5:1。Step (1) The nickel source is nickel nitrate, nickel chloride or other nickel salts, and the amount ratio of the nickel source to the tin dioxide substance is 1-5:1.
步骤(1)静置时间为12~24h,水浴锅温度为50~85℃。Step (1) the standing time is 12~24h, and the temperature of the water bath is 50~85°C.
步骤(1)高温还原是在氮气和氢气的混合气体下,以5~8℃/min的升温速率,升温至500~550℃,还原时间1~3h,其中氮气和氢气的体积比为95:5。Step (1) high temperature reduction is to be heated to 500 to 550 ° C with a heating rate of 5 to 8 ° C/min under the mixed gas of nitrogen and hydrogen, and the reduction time is 1 to 3 h, wherein the volume ratio of nitrogen and hydrogen is 95: 5.
步骤(2)抗生素废水中抗生素浓度为3~12mg/mL,抗生素为恩诺沙星、四环素或诺氟沙星,抗生素废水中的抗生素和研磨后的粉末的质量比为5~10:1。Step (2) The antibiotic concentration in the antibiotic wastewater is 3-12 mg/mL, the antibiotic is enrofloxacin, tetracycline or norfloxacin, and the mass ratio of the antibiotic in the antibiotic wastewater to the ground powder is 5-10:1.
步骤(2)还加入双氧水,双氧水与抗生素废水中的抗生素的物质的量比为5~57:1。In step (2), hydrogen peroxide is also added, and the substance ratio of the hydrogen peroxide to the antibiotics in the antibiotic wastewater is 5-57:1.
步骤(2)反应釜材质为哈式合金,容积为25mL,搅拌转速为400~500r/min,氧化反应温度为180~330℃,反应时间为0.5h以上。Step (2) The material of the reaction kettle is Hastelloy, the volume is 25mL, the stirring speed is 400-500r/min, the oxidation reaction temperature is 180-330°C, and the reaction time is more than 0.5h.
本发明的有益效果在于:The beneficial effects of the present invention are:
(1)使用亚超临界水技术,可以增强反应中的传质传热能力,加快对于抗生素接触反应过程,并且还能资源化降解抗生素产甲酸。(1) The use of sub-supercritical water technology can enhance the mass transfer and heat transfer capacity in the reaction, speed up the contact reaction process for antibiotics, and also degrade antibiotics to produce formic acid.
(2)使用浸渍法制备的Ni/SnO2催化剂,形成了NixSny合金,大大提升了催化活性,可以有效降低反应发生条件,并且催化剂制备过程简单,材料来源广泛,价格低廉。(2) The Ni/SnO 2 catalyst prepared by the impregnation method forms a NixSny alloy, which greatly improves the catalytic activity, can effectively reduce the reaction conditions, and the catalyst preparation process is simple, the source of materials is wide, and the price is low.
(3)本发明操作过程简单,材料来源广泛易得,能解决掉传质等限制因素,将抗生素废水快速高效降解,并且还能资源化产甲酸,实现了废水的综合治理及废物的资源化利用。(3) The present invention is simple in operation process, widely available in material sources, can solve the limiting factors such as mass transfer, degrade antibiotic wastewater quickly and efficiently, and can also recycle to produce formic acid, thus realizing comprehensive treatment of wastewater and recycling of waste. use.
附图说明Description of drawings
图1为实施例1中诺氟沙星的降解率图;Fig. 1 is the degradation rate figure of norfloxacin in
图2为实施例1中诺氟沙星降解反应中甲酸产量图;Fig. 2 is the formic acid yield figure in the norfloxacin degradation reaction among the
图3为实施例2中制得的Ni/SnO2催化剂的扫描电镜图;Fig. 3 is the scanning electron microscope picture of Ni/ SnO catalyst obtained in
图4为实施例2中制得的Ni/SnO2催化剂的X射线衍射图;Fig. 4 is the X-ray diffractogram of the Ni/ SnO catalyst obtained in Example 2;
图5为实施例2中制得的Ni/SnO2催化剂的H2-TPR曲线图;Fig. 5 is the H 2 -TPR curve diagram of the Ni/SnO 2 catalyst obtained in Example 2;
图6为实施例2中制得的Ni/SnO2催化剂的XPS图;Fig. 6 is the XPS figure of Ni/ SnO catalyst obtained in Example 2;
图7为实施例2中诺氟沙星降解率图;Fig. 7 is a graph of the degradation rate of norfloxacin in Example 2;
图8为实施例2中诺氟沙星降解反应中甲酸产量图;Fig. 8 is the formic acid yield figure in the norfloxacin degradation reaction among the
图9为实施例3中恩诺沙星的降解率图;Fig. 9 is the degradation rate figure of enrofloxacin among the
图10为实施例3中恩诺沙星降解反应中甲酸产量图;Fig. 10 is the formic acid output figure in the enrofloxacin degradation reaction among the
图11为实施例4中四环素的降解率图;Figure 11 is a graph of the degradation rate of tetracycline in Example 4;
图12为实施例4中四环素降解反应中甲酸产量图。FIG. 12 is a graph showing the yield of formic acid in the tetracycline degradation reaction in Example 4. FIG.
具体实施方式Detailed ways
下面通过实施例对本发明作进一步详细说明,但本发明不仅限于所述内容,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包括在本发明的保护范围之内。The present invention will be described in further detail below through the examples, but the present invention is not limited to the content, and any modifications, equivalent replacements and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention. within.
实施例1Example 1
一种抗生素废水降解并资源化的方法,具体步骤如下:A method for degrading and recycling antibiotic wastewater, the specific steps are as follows:
(1)称取硝酸镍和二氧化锡,其中硝酸镍和二氧化锡物质的量比为1:1,加入超纯水溶解,硝酸镍和二氧化锡总质量与超纯水的体积比g:mL为1:10,静置12h后在70℃水浴锅下搅拌至干燥,放在管式炉中,通入氮气和氢气混合气体下,以7℃/min的升温速率升温至550℃还原2h,待自然冷却后取出固体研磨,得到Ni/SnO2催化剂,其中氮气和氢气流量比为95:5;(1) take by weighing nickel nitrate and tin dioxide, wherein the amount ratio of nickel nitrate and tin dioxide substance is 1:1, add ultrapure water to dissolve, the volume ratio g of nickel nitrate and tin dioxide total mass and ultrapure water :mL is 1:10, after standing for 12 hours, stir to dry in a water bath at 70°C, put it in a tube furnace, pass in a mixed gas of nitrogen and hydrogen, and heat up to 550°C at a heating rate of 7°C/min to reduce 2h, after natural cooling, take out the solid and grind to obtain Ni/SnO 2 catalyst, wherein the flow ratio of nitrogen and hydrogen is 95:5;
(2)将步骤(1)制得的催化剂、抗生素废水添加至反应釜中,拧紧反应釜,其中抗生素废水浓度为7.7mg/mL,抗生素为诺氟沙星,抗生素废水中的抗生素和催化剂的质量比为5:1;(2) the catalyst and antibiotic waste water obtained in step (1) are added to the reaction kettle, and the reaction kettle is tightened, wherein the antibiotic waste water concentration is 7.7 mg/mL, and the antibiotic is norfloxacin, and the difference between the antibiotic and the catalyst in the antibiotic waste water is 7.7 mg/mL. The mass ratio is 5:1;
(3)设置反应釜内的温度为180℃,磁力转速为500r/min,反应0.5-6h。(3) Set the temperature in the reaction kettle to 180°C, the magnetic rotational speed to 500r/min, and the reaction for 0.5-6h.
图1为本实施例中诺氟沙星的降解率图,反应0.5h后降解率达到85%以上,反应时间延长,最终可以达到99%以上的降解率。Fig. 1 is a graph of the degradation rate of norfloxacin in this example. After 0.5h of reaction, the degradation rate reaches over 85%, and the reaction time is prolonged, and finally the degradation rate can reach over 99%.
图2为本实施例中诺氟沙星降解反应中甲酸产量图,可以看出在亚超临界水催化液化反应过程中,有甲酸的生成,产率在2%左右。Fig. 2 is a graph of the yield of formic acid in the degradation reaction of norfloxacin in the present embodiment, it can be seen that in the process of the sub-supercritical water catalytic liquefaction reaction, formic acid is generated, and the yield is about 2%.
实施例2Example 2
一种抗生素废水降解并资源化的方法,具体步骤如下:A method for degrading and recycling antibiotic wastewater, the specific steps are as follows:
(1)称取硝酸镍和二氧化锡,其中硝酸镍和二氧化锡物质的量比为1:1,加入超纯水溶解,硝酸镍和二氧化锡总质量与超纯水的体积比g:mL为1:10,静置12h后在70℃水浴锅下搅拌至干燥,放在管式炉中,通入氮气和氢气混合气体下,以7℃/min的升温速率升温至550℃还原2h,待自然冷却后取出固体研磨,得到Ni/SnO2催化剂,其中氮气和氢气流量比为95:5;(1) take by weighing nickel nitrate and tin dioxide, wherein the amount ratio of nickel nitrate and tin dioxide substance is 1:1, add ultrapure water to dissolve, the volume ratio g of nickel nitrate and tin dioxide total mass and ultrapure water :mL is 1:10, after standing for 12 hours, stir to dry in a water bath at 70°C, put it in a tube furnace, pass in a mixed gas of nitrogen and hydrogen, and heat up to 550°C at a heating rate of 7°C/min to reduce 2h, after natural cooling, take out the solid and grind to obtain Ni/SnO 2 catalyst, wherein the flow ratio of nitrogen and hydrogen is 95:5;
(2)将步骤(1)制得的催化剂、抗生素废水、双氧水添加至反应釜中,拧紧反应釜,其中抗生素废水浓度为7.7mg/mL,抗生素为诺氟沙星,抗生素废水中的抗生素和催化剂的质量比为5:1,双氧水、抗生素废水中的抗生素的物质的量比19:1;(2) catalyst, antibiotic waste water, hydrogen peroxide obtained in step (1) are added to the reaction kettle, and the reaction kettle is tightened, wherein the antibiotic waste water concentration is 7.7mg/mL, and the antibiotic is norfloxacin, and the antibiotics in the antibiotic waste water and The mass ratio of the catalyst is 5:1, and the amount ratio of the antibiotics in the hydrogen peroxide and the antibiotic wastewater is 19:1;
(3)设置反应釜温度为180℃,磁力转速为500r/min,反应0.5-6h。(3) The temperature of the reaction kettle is set to 180°C, the magnetic rotation speed is 500r/min, and the reaction is carried out for 0.5-6h.
图3为本实施例中制备的Ni/SnO2催化剂扫描电镜图,可以看出Ni/SnO2催化剂形成片状结晶,可以清晰看到晶格条纹。Fig. 3 is a scanning electron microscope image of the Ni/SnO 2 catalyst prepared in this example, it can be seen that the Ni/SnO 2 catalyst forms a sheet crystal, and the lattice fringes can be clearly seen.
图4为本实施例中制备的Ni/SnO2催化剂X射线衍射图,可以看到在催化剂中出现了NiO和NixSny的两个新峰。Figure 4 shows the X-ray diffraction pattern of the Ni/SnO 2 catalyst prepared in this example, and it can be seen that two new peaks of NiO and NixSny appear in the catalyst.
图5为本实施例中制得的Ni/SnO2催化剂H2-TPR曲线图,在610℃附近的峰应当是Sn,一般SnO2结构稳定,700℃以上才会被还原,如今在Ni掺杂下还原温度降低,表明了在金属之间发生协同作用,催化剂Ni/SnO2具有良好的氧化还原能力。Figure 5 shows the H 2 -TPR curve of the Ni/SnO 2 catalyst prepared in this example. The peak at around 610°C should be Sn. Generally, SnO 2 has a stable structure and will be reduced only after 700°C. The reduction temperature under the heterozygote decreases, indicating that a synergistic effect occurs between the metals, and the catalyst Ni/ SnO2 has a good redox ability.
图6为本实施例中制得的Ni/SnO2催化剂XPS图,图6(a)、(b)、(c)分别是氧元素、镍元素、锡元素的XPS图,图6(b)852.9eV出现的峰属于Ni的金属态,图6(c)485eV左右的峰属于Sn的金属态,可知通过浸渍法制备的Ni/SnO2催化剂中形成了NixSny合金,这是催化剂具有高活性的原因。Figure 6 is an XPS diagram of the Ni/ SnO catalyst prepared in this example, Figure 6 (a), (b), (c) are the XPS diagrams of oxygen element, nickel element, and tin element, respectively, Figure 6 (b) The peak at 852.9 eV belongs to the metallic state of Ni, and the peak around 485 eV in Figure 6(c) belongs to the metallic state of Sn. It can be seen that NixSny alloy is formed in the Ni/SnO 2 catalyst prepared by the impregnation method, which is the catalyst with high activity. reason.
图7为本实施例中诺氟沙星降解率图,可以看出诺氟沙星低温180℃反应0.5h后,降解率可以达到85%以上,反应时间延长,最终可以达到99%以上的降解率。Fig. 7 is a graph of the degradation rate of norfloxacin in this example. It can be seen that after the reaction of norfloxacin at a low temperature of 180°C for 0.5 h, the degradation rate can reach more than 85%, and the reaction time is prolonged, and finally the degradation can reach more than 99% Rate.
图8为本实施例中诺氟沙星降解反应中甲酸产量图,可以看出在亚超临界水催化液化反应过程中,有甲酸的生成,产率在3%左右。Fig. 8 is a graph of the yield of formic acid in the degradation reaction of norfloxacin in this example, it can be seen that in the process of the sub-supercritical water catalytic liquefaction reaction, formic acid is generated, and the yield is about 3%.
实施例3Example 3
一种抗生素废水降解并资源化的方法,具体步骤如下:A method for degrading and recycling antibiotic wastewater, the specific steps are as follows:
(1)称取硝酸镍和二氧化锡,其中硝酸镍和二氧化锡物质的量比为1:3,加入超纯水溶解,硝酸镍和二氧化锡总质量与超纯水的体积比g:mL为1:20,静置18h后在50℃水浴锅下搅拌至干燥,放在管式炉中,通入氮气和氢气混合气体下,以5℃/min的升温速率升温至500℃还原3h,待自然冷却后取出固体研磨,得到Ni/SnO2催化剂,其中氮气和氢气流量比为95:5;(1) take by weighing nickel nitrate and tin dioxide, wherein the amount ratio of nickel nitrate and tin dioxide substance is 1:3, add ultrapure water to dissolve, the volume ratio g of nickel nitrate and tin dioxide total mass and ultrapure water :mL is 1:20, after standing for 18 hours, stir to dryness in a 50°C water bath, put it in a tube furnace, pass in a mixed gas of nitrogen and hydrogen, and heat up to 500°C at a heating rate of 5°C/min to reduce 3h, after natural cooling, take out the solid and grind to obtain Ni/SnO 2 catalyst, wherein the flow ratio of nitrogen and hydrogen is 95:5;
(2)将步骤(1)制得的催化剂、抗生素废水、双氧水添加至反应釜中,拧紧反应釜,其中抗生素废水浓度为12mg/mL,抗生素为恩诺沙星,抗生素废水中的抗生素和催化剂的质量比为8:1,双氧水、抗生素废水中的抗生素的物质的量比5:1;(2) catalyst, antibiotic waste water, hydrogen peroxide prepared in step (1) are added in the reaction kettle, and the reaction kettle is tightened, wherein the antibiotic waste water concentration is 12 mg/mL, and the antibiotic is enrofloxacin, and the antibiotic and the catalyst in the antibiotic waste water The mass ratio of hydrogen peroxide and antibiotics in wastewater is 8:1, and the amount ratio of antibiotics in hydrogen peroxide and antibiotic wastewater is 5:1;
(3)设置反应釜温度为300℃,磁力转速为400r/min,反应0.5-6h。(3) The temperature of the reaction kettle is set to 300°C, the rotational speed of the magnetic force is 400r/min, and the reaction is carried out for 0.5-6h.
图9为本实施例中恩诺沙星的降解率图,可以发现恩诺沙星的降解率在0.5h达到94%以上。Fig. 9 is a graph of the degradation rate of enrofloxacin in this example, and it can be found that the degradation rate of enrofloxacin reaches more than 94% in 0.5h.
图10为本实施例中恩诺沙星降解反应中甲酸产量图,可以看出在亚超临界水催化液化反应过程中,有甲酸的生成,甲酸产量提高到20%~32%。Figure 10 is a graph of the formic acid yield in the enrofloxacin degradation reaction in this example, it can be seen that in the sub-supercritical water catalytic liquefaction reaction process, formic acid is generated, and the formic acid yield is increased to 20% to 32%.
实施例4Example 4
一种抗生素废水降解并资源化的方法,具体步骤如下:A method for degrading and recycling antibiotic wastewater, the specific steps are as follows:
(1)称取氯化镍和二氧化锡,其中氯化镍和二氧化锡物质的量比为1:5,加入超纯水溶解,氯化镍和二氧化锡总质量与超纯水的体积比g:mL为1:15,静置24h后在85℃水浴锅下搅拌至干燥,放在管式炉中,通入氮气和氢气混合气体下,以8℃/min的升温速率升温至540℃还原1h,待自然冷却后取出固体研磨,得到Ni/SnO2催化剂,其中氮气和氢气流量比为95:5;(1) take by weighing nickel chloride and tin dioxide, wherein the amount ratio of nickel chloride and tin dioxide substance is 1:5, add ultrapure water to dissolve, nickel chloride and tin dioxide total mass and ultrapure water The volume ratio of g:mL is 1:15. After standing for 24 hours, stir in a water bath at 85°C until dry, place it in a tube furnace, pass in a mixed gas of nitrogen and hydrogen, and heat up to 8°C/min. Reduction at 540 °C for 1 h, after natural cooling, the solid was taken out and ground to obtain a Ni/SnO 2 catalyst, in which the flow ratio of nitrogen and hydrogen was 95:5;
(2)将步骤(1)制得的催化剂、抗生素废水、双氧水添加至反应釜中,拧紧反应釜,其中抗生素废水浓度为3mg/mL,抗生素为四环素,抗生素废水中的抗生素和催化剂的质量比为10:1,双氧水、抗生素废水中的抗生素的物质的量比57:1;(2) catalyst, antibiotic waste water, hydrogen peroxide obtained in step (1) are added in the reaction kettle, and the reaction kettle is tightened, wherein the antibiotic waste water concentration is 3mg/mL, and the antibiotic is tetracycline, and the mass ratio of the antibiotic in the antibiotic waste water and the catalyst It is 10:1, and the substance ratio of the antibiotics in hydrogen peroxide and antibiotic wastewater is 57:1;
(3)设置反应釜温度为330℃,磁力转速为450r/min,反应0.5-6h。(3) The temperature of the reaction kettle is set to 330°C, the magnetic rotation speed is 450r/min, and the reaction is carried out for 0.5-6h.
图11为本实施例中四环素的降解率图,降解率在0.5h后达到96%左右。Figure 11 is a graph of the degradation rate of tetracycline in this example, and the degradation rate reaches about 96% after 0.5 h.
图12为本实施例中四环素降解反应中甲酸产量图,可以看出在亚超临界水催化液化反应过程中,有甲酸的生成,产率在3%左右。Figure 12 is a graph of the yield of formic acid in the tetracycline degradation reaction in this example. It can be seen that in the process of the sub-supercritical water catalytic liquefaction reaction, formic acid is generated, and the yield is about 3%.
从实施例1-4可以看出,降解反应高效快速,在0.5h内便能达到85%以上的降解率,双氧水的加入量在一定范围内会增加甲酸产量,这是由于双氧水的加入会在反应过程中产生具有强氧化性的羟基等自由基,能攻击抗生素的化学键,促进脱羧反应,并且在亚超临界水中,水会释放出氢,结合形成甲酸;另外一种途径是通过自由基进攻化学键,发生脱烷基化、羟基化等多种作用,将抗生素氧化降解成小分子醇类、醛类,最后进一步氧化生成甲酸,但是过量的双氧水会导致甲酸分解成CO2和H2O。It can be seen from Examples 1-4 that the degradation reaction is efficient and fast, and the degradation rate can reach more than 85% within 0.5h. The addition of hydrogen peroxide will increase the formic acid production within a certain range. This is because the addition of hydrogen peroxide will During the reaction, free radicals such as hydroxyl groups with strong oxidizing properties are generated, which can attack the chemical bonds of antibiotics and promote the decarboxylation reaction. In sub-supercritical water, water will release hydrogen and combine to form formic acid; another way is to attack by free radicals Chemical bonds, dealkylation, hydroxylation and other effects occur, oxidative degradation of antibiotics into small molecular alcohols and aldehydes, and finally further oxidation to form formic acid, but excessive hydrogen peroxide will cause formic acid to decompose into CO 2 and H 2 O.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110468942.2A CN113336308B (en) | 2021-04-28 | 2021-04-28 | A method for degrading and recycling antibiotic wastewater |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110468942.2A CN113336308B (en) | 2021-04-28 | 2021-04-28 | A method for degrading and recycling antibiotic wastewater |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113336308A CN113336308A (en) | 2021-09-03 |
CN113336308B true CN113336308B (en) | 2022-05-31 |
Family
ID=77468990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110468942.2A Active CN113336308B (en) | 2021-04-28 | 2021-04-28 | A method for degrading and recycling antibiotic wastewater |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113336308B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115999560B (en) * | 2023-02-08 | 2024-01-23 | 新乡医学院 | Nickel cobaltate/tin oxide composite catalyst and preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3868464A (en) * | 1970-10-27 | 1975-02-25 | Meiji Seika Kaisha | Production of maltose with amylases produced by streptomyces |
CN101845647A (en) * | 2009-03-26 | 2010-09-29 | 株式会社神户制钢所 | Copper or the copper alloy and the manufacture method thereof of the band Sn coating of excellent heat resistance |
CN109603870A (en) * | 2018-12-20 | 2019-04-12 | 大连理工大学 | Preparation and Application of a Bimetallic Substituted Solid Heteropoly Salt Composite Catalyst |
CN111545212A (en) * | 2020-04-29 | 2020-08-18 | 南京中微纳米功能材料研究院有限公司 | Double perovskite La2NiFeO6Method for catalytic degradation of antibiotic wastewater |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009291665A (en) * | 2008-06-02 | 2009-12-17 | Nippon Meat Packers Inc | Separation method of oil |
CA2900139A1 (en) * | 2013-02-05 | 2014-08-14 | Basf Se | Method for producing porous or fine-particle solid inorganic materials |
CN107001064B (en) * | 2014-12-19 | 2019-10-25 | 三井金属矿业株式会社 | Contain the granules of stannic oxide of halogen and its manufacturing method |
CN104689812B (en) * | 2014-12-26 | 2018-09-04 | 南京大学 | Ce3-xSbxTaO7The compound porous catalysis material of coal ash zeolite prepares and application |
CN104525182B (en) * | 2014-12-26 | 2018-11-30 | 南京大学 | Cerium niobium antimony base composite particles photochemical catalyst, preparation and the application of porous nanometer structure |
CN104556964A (en) * | 2014-12-30 | 2015-04-29 | 纳诺科技有限公司 | A kind of hydrophobic silica airgel thermal insulation composite material and preparation method thereof |
CN108147521A (en) * | 2017-01-09 | 2018-06-12 | 厦门康浩生态农业有限公司 | A kind of efficient method for reducing antibiotic content in livestock and poultry feces |
WO2019236525A1 (en) * | 2018-06-04 | 2019-12-12 | Cocoon Biotech Inc. | Silk-based product formulations and methods of use |
CN112044915A (en) * | 2020-06-19 | 2020-12-08 | 中国科学院生态环境研究中心 | Novel method for completely harmless and efficient recycling of waste antibiotic medicines |
-
2021
- 2021-04-28 CN CN202110468942.2A patent/CN113336308B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3868464A (en) * | 1970-10-27 | 1975-02-25 | Meiji Seika Kaisha | Production of maltose with amylases produced by streptomyces |
CN101845647A (en) * | 2009-03-26 | 2010-09-29 | 株式会社神户制钢所 | Copper or the copper alloy and the manufacture method thereof of the band Sn coating of excellent heat resistance |
CN109603870A (en) * | 2018-12-20 | 2019-04-12 | 大连理工大学 | Preparation and Application of a Bimetallic Substituted Solid Heteropoly Salt Composite Catalyst |
CN111545212A (en) * | 2020-04-29 | 2020-08-18 | 南京中微纳米功能材料研究院有限公司 | Double perovskite La2NiFeO6Method for catalytic degradation of antibiotic wastewater |
Also Published As
Publication number | Publication date |
---|---|
CN113336308A (en) | 2021-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113896299B (en) | electro-Fenton reaction cathode material of ferromanganese layered double metal hydroxide loaded biochar, and preparation method and application thereof | |
CN113385203A (en) | Preparation method of core-shell structure bimetal phosphide nano-array | |
CN113546648B (en) | Preparation method of ultrathin nano wafer-shaped BiOBr high-activity photocatalyst | |
CN110813349A (en) | A kind of binary metal oxide composite carbon nitride catalyst and its preparation method and application | |
CN113336308B (en) | A method for degrading and recycling antibiotic wastewater | |
CN1290608C (en) | Catalyst and its prepn process and use | |
CN103551152B (en) | A kind of carbon back non noble metal oxygen reduction catalyst | |
CN119243216A (en) | A synthesis method and application of Cu/Ni, Cu/Zn bimetallic conductive MOF-based catalyst for enhancing nitrate reduction to ammonia | |
CN118045623A (en) | High-performance nitrogen-doped modified lignite-supported cobalt catalyst and preparation method and application thereof | |
CN116408117B (en) | Heterojunction type photocatalytic material with hierarchical structure and preparation method thereof | |
CN115814829B (en) | Co and Mo2C-codoped biochar-based composite material and preparation method and application thereof | |
CN117680183A (en) | Preparation method and application of a Co and Cu co-doped CN-based composite material | |
CN117680181A (en) | An ultra-high loading single-atom copper catalyst and its preparation method and application | |
CN113522338B (en) | Application of Boron-Oxygen Co-Doped Carbon Nitride Nonmetallic Ozone Catalysts | |
CN116673056A (en) | Preparation method of Fe-g-C3N4/MoO3-x photocatalyst and its application in removal of humic acid from water by photo-Fenton oxidation | |
CN116618049A (en) | Synthesis method of copper monoatomic nano-enzyme and catalytic antibacterial application thereof | |
CN116219473A (en) | Preparation and application methods of in-situ self-optimizing atomic-level copper catalyst | |
CN117258844A (en) | Preparation method of Co (II) visible light catalyst containing mixed ligand | |
CN114976052A (en) | Preparation method of grain boundary-rich ultrathin rhodium nanosheet electrocatalyst | |
CN113097499A (en) | FeNi/NiFe2O4@ NC composite material and preparation method and application thereof | |
CN115241472B (en) | An oxygen reduction catalyst having a platinum-bismuth alloy shell layer and its preparation method and application | |
CN114373952B (en) | Preparation method and application of surface reconstructed PdFe/Cu nano-electrocatalyst for fuel cells | |
CN115896855B (en) | A nickel-iron-based metal alkoxide catalyst and its preparation method and application | |
CN119186600B (en) | A Fe2Zn3S5-styrene-butadiene rubber composite Fenton catalyst and its preparation method and application | |
CN119926406A (en) | Iron-cobalt-nickel layered double hydroxide/graphite-alkyne nanocomposite and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |